Fitbit has announced the Fitbit Heart Study, a large-scale virtual study with users that will validate its use of Fitbit devices to identify conditions like atrial fibrillation (AFib). It will be open ...

Fitbit has completed clinical trials of its own ECG feature and is looking to get FDA approval – as it launches a large scale study into Afib and irregular heart rate detection. The mass Fitbit Heart ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

Great hardware, messy software ...

The electrocardiogram built into recent Apple Watch models isn’t likely to give wearers false notifications that they have atrial fibrillation, a potentially dangerous heart condition. A clean bill of ...

Garmin has announced a new ECG app for AFibVenu 2 Plus smartwatch users. This app is cleared by the U. S. Food and Drug Administration (FDA) and allows anyone with the Venu 2 Plus to record their ...

Regulatory agencies in the United States and Europe have now approved Fitbit’s ECG app to identify atrial fibrillation, making it the second smartwatch to be cleared for this indication. Yesterday, ...

A new artificial intelligence (AI) model designed by Scripps Research scientists could help clinicians better screen patients for atrial fibrillation (or AFib) - an irregular, fast heartbeat that is ...

Compared with regular checks in primary care, continuous ECG monitoring revealed more asymptomatic older people with hypertension as having atrial fibrillation (Afib), the SCREEN-AF trial showed. The ...

Tempus AI, Inc. (NASDAQ:TEM) is one of the 12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On. On June 11, 2026, Tempus AI, Inc. (NASDAQ:TEM) announced that a multi-center validation of ...

Using the ECG on Apple Watch Series 4 is dead easy. Photo: Lewis Wallace/Cult of Mac Ed Dentel has become the poster child for the new ECG function of the Apple Watch. He installed the recent update ...